Viking Therapeutics Stock Surges 100% on Positive Weight-Loss Drug Trial
Patients saw ‘significant’ reductions in body weight during a study of a weight-loss drug developed by Viking Therapeutics.
Source: marketwatch.com
📰 Novob Ko News
Novob Ko News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Novob Ko. Real-time updates on events, politics, business and more.
Healthcare Stocks Are Priced for a Fire Sale. These 6 Funds Can Ride Them Higher.
Actively managed mutual funds make sense when investing in healthcare, since companies’ future prospects are often difficult for the market to price...
Source: marketwatch.com
Coca-Cola Meets Earnings Estimates and Beats on Sales. Higher Prices Help.
Coca-Cola posts fourth-quarter adjusted earnings of 49 cents a share, matching estimates.
Source: marketwatch.com
A Dividend Investing Strategy Makes Sense Now. Here Are More Than 20 Picks.
Many high-yielding sectors of the market are undervalued right now, and collecting dividends has several advantages over clipping coupons on bonds.
Federal Reserve Article Normal Electricity Gas Utilities Electric Power Generation Agricultural Machinery Plastics Products
Source: marketwatch.com
Dividend Stocks Make Sense Now. Here Are More Than 20 to Consider.
Many high-yielding sectors of the market are undervalued right now, and collecting dividends has several advantages over clipping coupons on bonds.
Federal Reserve Article Normal Electricity Gas Utilities Electric Power Generation Agricultural Machinery Plastics Products
Source: marketwatch.com
Liver Disease Biotechs' Stocks Crash on Eli Lilly's Mounjaro Data
New clinical trial results from El Lilly suggest its Type 2 diabetes and weight-loss drug, tirzepatide, could upend the incipient market for MASH treatments.
Source: marketwatch.com
Novo Nordisk: Focus in 2024 on Reaching More Patients, Progressing and Expanding Pipeline, Continued Significant Expansion of Production Capacity
By Dominic Chopping Danish pharmaceutical giant Novo Nordisk has started to gradually increase the supply of lower-dose strengths of its blockbuster Wegovy...
Novo Nordisk Dominic Chopping Article Normal Healthcare Life Sciences Financial Performance Sales Figures
Source: marketwatch.com
Microsoft, Alphabet, AMD, Tesla, Walmart, Boeing, Paramount, and More Market Movers
Microsoft’s fiscal second-quarter earnings and revenue beat analysts’ expectations, advertising sales at Alphabet miss estimates, AMD issues a weak...
Federal Reserve Article Normal Computers Consumer Electronics Applications Software Aerospace Products Parts Civil Aircraft
Source: marketwatch.com
Weight-Loss Drug Boom Sends Novo Nordisk Profits Soaring. Why the Success Brings Challenges.
Novo Nordisk is on to a real winner with its popular weight-loss drug Wegovy. The company's market capitalization climbed past $500 billion early Wednesday.
Source: marketwatch.com
ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment
Chief Executive Mick Farrell expects the drugs will be used to complement proven treatments.
Source: marketwatch.com